Discharge on Sliding Scale and Lantus: A Dangerous and Ineffective Approach
Discharging a patient with a random blood glucose of 300 mg/dL on sliding-scale insulin alone with Lantus 25 units is fundamentally inadequate and contradicts all major diabetes guidelines. This reactive approach will perpetuate dangerous glucose fluctuations and fails to address both fasting and post-prandial hyperglycemia.
Why This Regimen Is Condemned by Guidelines
The American Diabetes Association and all major diabetes societies explicitly condemn sliding-scale insulin (SSI) as monotherapy because it treats hyperglycemia only after it occurs, creating a dangerous cycle of hyperglycemia → large correction → hypoglycemia → rebound hyperglycemia. 1 Only approximately 38% of patients achieve mean glucose <140 mg/dL with SSI alone, versus 68% with a scheduled basal-bolus regimen—demonstrating clear inferiority. 1, 2, 3
Sliding-scale insulin provides no scheduled prandial coverage, leaving post-meal glucose spikes unaddressed until they are reactively corrected hours later. 1, 3 This patient's glucose of 300 mg/dL signals both inadequate basal insulin AND uncontrolled post-prandial excursions that require scheduled mealtime insulin, not just correction doses. 1
The Correct Discharge Regimen
Immediate Basal Insulin Adjustment
Increase Lantus aggressively by 4 units every 3 days until fasting glucose consistently reaches 80-130 mg/dL. 1 For a patient with glucose of 300 mg/dL, the starting dose of 25 units is likely insufficient; most patients with this degree of hyperglycemia require 0.3-0.5 units/kg/day total insulin (approximately 21-35 units for a 70 kg patient as basal alone, with additional prandial insulin). 1
Stop basal escalation when the dose approaches 0.5 units/kg/day (approximately 35-50 units for most adults) to avoid "over-basalization." 1 Clinical signals that further basal increases are futile include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, or high glucose variability. 1
Add Scheduled Prandial Insulin Immediately
Initiate rapid-acting insulin (lispro, aspart, or glulisine) at 4 units before each of the three largest meals (or approximately 10% of the current basal dose). 1, 2, 3 Administer this 0-15 minutes before meals for optimal post-prandial control. 1, 2
Titrate each meal dose by 1-2 units (approximately 10-15%) every 3 days based on 2-hour post-prandial glucose readings, targeting <180 mg/dL. 1, 2 This scheduled prandial insulin is essential—correction doses alone cannot replace it. 1, 3
Correction Insulin Protocol (Adjunct Only)
Use correction doses only as supplements to scheduled basal and prandial insulin, never as replacements. 1, 2, 3 Add 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL and 4 units for glucose >350 mg/dL, in addition to the scheduled prandial dose. 1, 2
Continue or Optimize Metformin
Continue metformin at the maximum tolerated dose (up to 2,000-2,550 mg daily) unless contraindicated. 1 Metformin reduces total insulin requirements by 20-30% and provides superior glycemic control compared with insulin alone. 1 Never discontinue metformin when starting or intensifying insulin unless specific contraindications exist (renal impairment, acute illness, tissue hypoxia). 1
Monitoring and Titration Schedule
Check fasting glucose daily during the titration phase to guide Lantus adjustments. 1, 2 Measure pre-meal glucose before each meal to calculate correction doses. 1 Obtain 2-hour post-prandial glucose after each meal to assess prandial insulin adequacy. 1
Reassess insulin doses every 3 days while actively titrating. 1 Check HbA1c every 3 months until stable control is achieved. 1
Expected Clinical Outcomes
With properly implemented basal-bolus therapy, approximately 68% of patients achieve mean glucose <140 mg/dL, compared with only 38% using sliding-scale alone. 1, 2, 3 HbA1c reductions of 2-3% (or 3-4% in severe hyperglycemia) are achievable within 3-6 months with intensive insulin titration combined with metformin. 1
Properly executed basal-bolus regimens do not increase overall hypoglycemia incidence compared with inadequate sliding-scale approaches. 1, 2, 3
Critical Pitfalls to Avoid
Never discharge a patient on sliding-scale insulin as the sole regimen when glucose values are 300 mg/dL—this approach is condemned by all major diabetes guidelines and will result in continued poor control. 1, 2, 3
Do not delay adding prandial insulin when glucose is this elevated; the level of hyperglycemia mandates both basal and mealtime coverage from the outset. 1
Never rely solely on correction doses without adjusting scheduled basal and prandial insulin—this perpetuates the reactive cycle that causes dangerous glucose fluctuations. 1, 3
Do not continue escalating Lantus beyond 0.5-1.0 units/kg/day without addressing post-prandial hyperglycemia with prandial insulin, as this leads to over-basalization with increased hypoglycemia risk and suboptimal control. 1
Hypoglycemia Management Education
Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed. 1, 2 If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10-20% immediately. 1, 2
Provide comprehensive patient education on hypoglycemia recognition and treatment, proper insulin injection technique and site rotation, self-monitoring of blood glucose, "sick day" management rules, and insulin storage and handling. 1